Professionals
Menu Professionals
-
- Conferences
- Translator of Medical Dermatological Terms
- Management opinions
- Patient-oriented Therapeutical Explanations
- Patient Support Groups
- Conference Notes
- Collection of Old Dermatology Books
- Controversy
- "Introduction au Portail d'Informations Globale Dermatologie"
- Presentations
- Specialized Subjects in Dermatology
- Teledermatology
- Industries at the service of Dermatology
- Scientific Literature
- Articles
- History & Terminology
- VIPs
Doctor reviews and what to do when you get them
Sunday, March 23rd, 2014When getting a new patient, it is often secondary to recommendation by patients in their network. It’s the same for social media except that it is not word-of-mouth but word of mouth on steroids. Here is an example of rating sites which include doctors in the United States: Yelp Healthgrades Vitals Zocdoc Webmd Doctors […]
Social media in Dermatology
Sunday, March 23rd, 2014Milestones in invention of e-technologies 1971 – Email 1985 – AOL 1993 – www (internet) 1998 – Google 2001 – Wikipedia 2004 – Facebook 2005 – Youtube 2006 – Twitter 2007 – Iphone 2010 – Ipad All technologies have evolved and they are being used with different frequencies – for example today emails are used […]
Treating warts with Cryotherapy by understanding its principles
Sunday, March 23rd, 2014How does cryosurgery/cryotherapy work ? Cryotherapy acts by taking the heat out of tissues. To take the heat out conduction of heat is important: it is highest for metals ( for example with probes), then ice (for example freezing just after having done it once), then water (by wetting the lesion to be treated and […]
Rosacea (Acne Rosacea): another topical treatment
Sunday, March 23rd, 2014Rosacea is a common dermatological condition affecting 0,5 – 1 % of the population which represents over 15 million individuals in the United States It is sometimes classified in stages 1 (erythema and telangiectasia), 2 and 3 (rhinophyma). It is an important cause of distress and social withdrawal. Around 60% of individuals with stage 1 […]
Psoriasis: a Therapeutic approach
Sunday, March 23rd, 2014In deciding which therapy to use, many factors must be taken into consideration, including safety, efficacy, availability, and cost. Long-term side effects will, of course, become better known as experience with each therapy grows. In particular, biologic medications are already in their second decade of use in rheumatology, but there is much less experience than […]
Rosacea (Acne Rosacea): protective effects of Canthelicidins and the importance of the Skin Barrier (treatment tips)
Sunday, March 23rd, 2014Rosacea is still a mystery with regards to etiology but it has been suggested that the Demodex mite might be associated with its presence and/or severity. Canthelicidines are antimicrobial peptides that protect the skin through: direct antimicrobial activity by initiating a hosp response resulting in cytokine release, inflammation, angiogenesis and reepitheliazation. In rosacea the […]
Acitretin in the treatment of Psoriasis
Sunday, March 23rd, 2014Acitretin, like all retinoids, promote the differentiation of keratinocytes. It is useful in combination with other therapies, particularly with phototherapy, or as a maintenance therapy after control with a faster reacting agent. Dosing of acitretin is usually started at 10-25 mg per day, with a slow titration up in dose. Recent studies have shown that […]
Treating Acne Scars with Adapalene (vitamine A derivative)
Sunday, March 23rd, 2014Acne scarring is a common complaint in acne patients. This is a visible sequlae of active acne and persists for a lifetime. Treatments can be costly and include chemical peels and fractionated CO2 laser therapy. This study measures the effect of adapalene in the treatment of acne scars Methods prospective study single-center, open-label, pilot study […]
Adalimumab (Humira) in the Treatment of Psoriasis
Sunday, March 23rd, 2014Adalimumab is a monoclonal antibody against TNF. It is currently approved for the treatment of psoriatic and rheumatoid arthritis and ankylosing spondylitis. Dosing is 40 mg subcutaneously every other week. Phase III trial results showed excellent results in the treatment of psoriasis. There has also been a recent placebo controlled trial presented comparing methotrexate to […]
Infliximab (Remicade) in the Treatment of Psoriasis
Sunday, March 23rd, 2014Infliximab is a chimeric monoclonal antibody against TNF, with human constant regions and murine variable regions. Studies have shown that it is the most effective biologic agent for the treatment of psoriasis at the usually prescribed doses. Since dosing is weight-based (start 0.5 mg/kg on weeks 0, 2, and 6, then 0.5 mg/kg every 8 […]
